B7-33: interpreting anti-fibrosis findings in mice

Evidence discussed: Animal study.

What the researchers studied

B7-33 is a single-chain derivative designed to retain selected actions of relaxin. In mice with induced heart injury, researchers compared B7-33, relaxin and perindopril. B7-33 reduced several measures of inflammation and fibrosis and affected vascular measurements. [1]

How to interpret the result

The comparison used a specific injury model and observation window. It does not establish superiority to perindopril in patients. Mouse tissue measurements are not equivalent to preventing heart failure or death in humans.

What readers can take from it

The scientific question is whether a simpler relaxin-derived structure can preserve useful signaling. Clinical translation requires separate evidence on exposure, safety and patient outcomes.

This original editorial summary provides no diagnosis, dosing or treatment advice. The study did not test or certify a PeptiKing product.

Source

[1] Alam et al., B7-33 in experimental cardiomyopathy (2023). PMID: 36753958. Based on the PubMed-indexed abstract and record; full-text methods were not independently reviewed.